“…Using two arsenic derivatives [biotin-conjugated versions of p -aminophenylarsine oxide (PAPAO) and 4,6-bis(1,3,2-dithiarsolan-2-yl)-7-hydroxy-3 H -phenoxazin-3-one (ReAsH)], Zhang and colleagues proposed that ATO binds to a distinctive form of nuclear bodies . Fluorescent probes, for example, (4 E )-4-(2-hydroxybenzylideneamino)-1,2-dihydro-2,3-dimethyl-1-phenylpyrazol-5-one (APSAL) and 4-methyl-2,6-bis(( E )-(pyridin-2-ylmethylimino)methyl)phenol (DFPPIC), have also been used to assess the distribution of arsenic within cells. , In those studies, however, one could never be certain that the distribution of the fluorescently labeled arsenic compounds accurately reflects the distribution of ATO in cells simply because the fluorescent tags themselves could potentially bind in a nonspecific manner to a variety of molecules and organelles in cells. Such interactions could create a misleading impression of ATO pharmacokinetics.…”